0.0350CAD+16.67%Mkt Cap: 5.92M CADP/E: —Last update: 2026-06-01
Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap5.92M CAD
Enterprise Value6.02M CAD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-1.80M CAD
Revenue/Share—
Last Price0.0350 CAD
Fiscal Year EndJan 2025
MR QuarterOct 2025
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.22
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.030017% of range0.0600
52W High0.0600 CAD
52W Low0.0300 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-8.42%
ROA-7.98%
Growth
Revenue Growth—
Earnings Growth3010.20%
Cash Flow & Leverage
Operating CF-511.88K CAD
CapEx (TTM)—
FCF Margin—
FCF Yield-2.11%
Net Debt941.76K CAD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.05
Current Ratio0.07
Quick Ratio0.05
Book Value/Sh0.1360 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield67.86%
Payout Ratio0.00%
Ex-Div DateJul 21, 2005
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.169.13M
Float138.75M
Insiders16.88%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short698
Short (prev mo.)5.24K
Technical
SMA 500.0350 (+0.0%)
SMA 2000.0382 (-8.3%)
Beta-0.25
S&P 52W Chg27.70%
Avg Vol (30d)27.45K
Avg Vol (10d)19.15K
Technical Indicators
RSI (14)35.3
MACD-0.0005
MACD Signal0.0007
MACD Hist.-0.0012
BB Upper0.0455 CAD
BB Middle0.0380 CAD
BB Lower0.0305 CAD
BB Width39.68%
ATR (14)0.0023 CAD
Vol Ratio (20d)0.03x